［1］YOUNG RJ,BROWN NJ,REED MW,et al.Angiosarcoma［J］.The Lancet Oncology,2010,11(10):983-991.
［2］ARORA TK,TERRACINA KP,SOONG J,et al.Primary and secondary angiosarcoma of the breast［J］.Gland Surg,2014,3(1):28-34.
［3］MCCLELLAND S,HATFIELD J,DEGNIN C,et al.Extent of resection and role of adjuvant treatment in resected localized breast angiosarcoma［J］.Breast Cancer Res Treat,2019,175(2):409-418.
［4］TAFFURELLI M,PELLEGRINI A,MEATTINI I,et al.Secondary breast angiosarcoma:A multicentre retrospective survey by the National Italian Association of Breast Surgeons(ANISC)［J］.Breast,2019,45：56-60.
［5］BAKER GM,SCHNITT SJ.Vascular lesions of the breast［J］.Semin Diagn Pathol,2017,34(5):410-419.
［6］MASAI K,KINOSHITA T,JIMBO K,et al.Clinicopathological features of breast angiosarcoma［J］.Breast Cancer,2016,23(5):718-723.
［7］GERVAIS MK,BURTENSHAW SM,MAXWELL J,et al.Clinical outcomes in breast angiosarcoma patients:A rare tumor with unique challenges［J］.J Surg Oncol,2017,116(8):1056-1061.
［8］HODGSON NC,BOWEN-WELLS C,MOFFAT F,et al.Angiosarcomas of the breast:A review of 70 cases［J］.Am J Clin Oncol,2007,30(6):570-573.
［9］FARRAN Y,PADILLA O,CHAMBERS K,et al.Atypical presentation of radiation-associated breast angiosarcoma:A case report and review of literature［J］.Am J Case Rep,2017,18:1347-1350.
［10］SALMINEN SH,WIKLUND T,SAMPO MM,et al.Treatment and prognosis of radiation-associated breast angiosarcoma in a nationwide population［J］.Ann Surg Oncol,2020,27(4):1002-1010.
［11］ABDOU Y,ELKHANANY A,ATTWOOD K,et al.Primary and secondary breast angiosarcoma:Single center report and a Meta-analysis［J］.Breast Cancer Res Treat,2019,178(3):523-533.
［12］WU WH,JI QL,LI ZZ,et al.Mammography and MRI manifestations of breast angiosarcoma［J］.BMC Womens Health,2019,19(1):73.
［13］刘红,赵晶,付丽.乳腺原发性血管肉瘤的诊断治疗进展［J］.中国肿瘤临床,2006,33(15):897-899.
LIU H,ZHAO J,FU L.The diagnosis and treatment of primary breast haemangiosarcoma［J］.Chinese Clinical Oncology,2006,33(15):897-899.
［14］郭炳君,李凡.原发性乳腺血管肉瘤的超声诊断［J］.中国超声医学,2023,39(4):456-458.
GUO BJ,LI F.Ultrasonic diagnosis of primary angiosarcoma of the breast［J］.Chinese Journal of Ultrasound in Medicine,2023,39(4):456-458.
［15］NI Y,XIE X,BU H,et al.Concurrent primary angiosarcoma and invasive ductal carcinoma in the same breast［J］.J Clin Pathol,2013,66(3):263-264.
［16］赵刚.现代乳腺肿瘤学［M］.武汉：武汉大学出版社,2017:131-144.
ZHAO G.Modern breast oncology［M］.Wuhan:Wuhan University Publishing House,2017:131-144.
［17］GUTKIN PM,GANJOO KN,LOHMAN M,et al.Angiosarcoma of the breast:Management and outcomes［J］.Am J Clin Oncol,2020,43(11):820-825.
［18］DOGAN A,KERN P,SCHULTHEIS B,et al.Radiogenic angiosarcoma of the breast:Case report and systematic review of the literature［J］.BMC Cancer,2018,18(1):463.
［19］FRAGA-GUEDES C,ANDRE S,MASTROPASQUA MG,et al.Angiosarcoma and atypical vascular lesions of the breast:Diagnostic and prognostic role of MYC gene amplification and protein expression［J］.Breast Cancer Res Treat,2015,151(1):131-140.
［20］YAN M,GILMORE H,BOMEISL P,et al.Clinicopathologic and immunohistochemical study of breast angiosarcoma［J］.Ann Diagn Pathol,2021,54:151795.
［21］GEORGE ZG,FAIRWEATHER M,WANG J,et al.Cutaneous radiation-associated breast angiosarcoma:Radicality of surgery impacts survival［J］.Ann Surg,2017,265(4):814-820.
［22］SEINEN JM,STYRING E,VERSTAPPEN V,et al.Radiation-associated angiosarcoma after breast cancer:High recurrence rate and poor survival despite surgical treatment with R0 resection［J］.Ann Surg Oncol,2012,19(8):2700-2706.
［23］ZDRAVKOVIC D,GRANIC M,CRNOKRAK B.Proper treatment of breast angiosarcoma-mastectomy or breast conserving surgery［J］.Breast Cancer Res Treat,2020,179(3):765.
［24］MERGANCOVA J,LIEROVA A,COUFAL O,et al.Radiation-associated angiosarcoma of the breast:An international multicenter analysis［J］.Surg Oncol,2022,41:101726.
［25］FODOR J,OROSZ Z,SZABO E,et al.Angiosarcoma after conservation treatment for breast carcinoma:Our experience and a review of the literature［J］.J Am Acad Dermatol,2006,54(3):499-504.
［26］TORRES KE,RAVI V,KIN K,et al.Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer［J］.Ann Surg Oncol,2013,20(4):1267-1274.
［27］DEPLA AL,SCHARLOO-KARELS CH,DE JONG MAA,et al.Treatment and prognostic factors of radiation-associated angiosarcoma(RAAS) after primary breast cancer:A systematic review［J］.Eur J Cancer,2014,50(10):1779-1788.
［28］MOCELLIN S,ROSSI CR,BRANDES A,et al.Adult soft tissue sarcomas:Conventional therapies and molecularly targeted approaches［J］.Cancer Treat Rev,2006,32(1):9-27.
［29］RIEDLINGER G,HADIGOL M,KHIABANIAN H,et al.Association of JAK2-V617F mutations detected by solid tumor sequencing with coexistent myeloproliferative neoplasms［J］.JAMA Oncol,2019,5(2):265-267.
［30］TENG L,YAN S,DU J,et al.Clinicopathological analysis and prognostic treatment study of angiosarcoma of the breast:A SEER population-based analysis［J］.World J Surg Oncol,2023,21(1):144.
［31］RONEN S,IVAN D,TORRES-CABALA CA,et al.Post-radiation vascular lesions of the breast［J］.J Cutan Pathol,2019,46(1):52-58.
［32］VORBURGER SA,XING Y,HUNT KK,et al.Angiosarcoma of the breast［J］.Cancer,2005,104(12):2682-2688.
［33］D'ANGELO SP,ANTONESCU CR,KUK D,et al.High-risk features in radiation-associated breast angiosarcomas［J］.Br J Cancer,2013,109(9):2340-2346.
［34］SALMINEN SH,BLOMQVIST CP.ASO author reflections:Registry-based analysis of padiation-associated angiosarcoma of the breast provides unbiased insights into this disease［J］.Ann Surg Oncol,2020,27(4):1011-1012.
［35］HU CC,CHANG TH,HSU HH.Case of low-grade primary angiosarcoma of the breast with early recurrence［J］.Breast J,2019,25(3):502-504.